Rory Spiegel
@EMNerd_
Followers
7K
Following
7K
Media
160
Statuses
5K
Sunday morning teaching session for fellows and attending at @SHEBA_ Trying to break old habits.. Thanks @ThinkingCC @EMNerd_ @MaxHockstein
7
3
30
🚨 Introducing Real Debate—a new column by Dr. Rory Spiegel. In a world rushing through patient care for profit, let’s reclaim space for curiosity, dialogue, and thoughtful exploration. @EMNerd_ @ACEPNation #EmergencyMedicineNews
https://t.co/cRwsrIidZV
1
3
4
Never saw this one! The VeXLUS! Love it! (79) Evaluation Of Congestion Levels in Septic Patients Admitted to Critical Care Units with a Combined Venous Excess-Lung Ultrasound Score (VExLUS) – a Research Protocol
2
9
30
Thanks to @khaycock2 @EMNerd_ @Ad12Andre and @WBeaubien for their invaluable help! Hopefully this can reframe some common issues we see and hear about :-)
theultrasoundjournal.springeropen.com
There has been a significant interest in venous congestion in recent years, among which the VExUS score has been prominent, both in clinical practice and research efforts. We have noted some recurr...
1
18
45
Check out the October edition of Annals through the lenses of @emlitofnote and @EMNerd_ : https://t.co/JMamp2RcLL (or wherever you listen to podcasts)
1
3
4
0
7
11
Well, it's already nov 1 in much of the world so... #HR25 registration is live!!! Small and intimate venue this year, and current early bird tickets, so don't wait too long!!!
thinkingcriticalcare.com
A few words about it… HR2025 is about putting it all together. We’ve been talking about the venous side for a long time and it has been fantastic seeing how much it has taken off – at l…
2
16
23
hard cosign. I explained why this study is incorrect over a *decade* ago! https://t.co/nLWrTeAo53 if you actually believe that giving antibiotics an hour earlier reduces mortality by 8%, please DM me about some oceanside properties in vermont to invest in.
emcrit.org
0 Time and tide wait for no intervention                - Geoffrey Chaucer 0 We are barraged by time-to-intervention studies
WILL PEOPLE PLEASE STOP CITING KUMAR ET AL CRIT CARE MEDICINE 2006 AND CLAIMING a 7.6% MORTALITY DECREASE PER HOUR WITH ANTIBIOTICS. THIS IS COMPLETELY NOT TRUE AND HAS BEEN KNOWN FOR YEARS! god this zombie fact WILL NOT die. There are RCT's on the topic!! No effect!!
7
32
182
Into the wikeawades warld from sleep we are passing. https://t.co/iD7Uq0Bs7l
@iceman_ex
@avkwong
@ThinkingCC
@ross_prager
@EMNerd_
@CriticalCareNow
@MaxHockstein
@JeiblMy
@corinnetheCOS
@khaycock2
@SCCM
@StanleyCup
#echofirst
ccforum.biomedcentral.com
1
11
20
Ok. So in the early phases of finally planning #HRBeachResus25. Here is a poll for those potentially interested. If you are, pls email hospresusconference@gmail.com with above # as subject. Let's imagine it will be in a warm, exotic location. In the polls below, select ur answer
1
6
7
Thanks for following along! There are colleagues with great presentations and reviews on APRV @MaxHockstein @EMNerd_ @ThinkingCC Useful references: PMID: 34593706 DOI: 10.1097/CCM.0000000000005312 PMID: 35953213 DOI: 10.1016/j.emc.2022.05.004
6
12
63
@IM_Crit_ @MaxHockstein @EMNerd_ @ThinkingCC Great summary. @EMNerd_ gives a good breakdown of his approach here
0
1
7
Are you "APRV curious" but lacking the practical know-how? @EMNerd_ tells all: how to start it, the common pitfalls, how to wean and transition, whether it's lung protective, and more. #medtwitter #FOAMcc #FOAMed #meded #pulmcc #ventrounds #some4mv
https://t.co/00uMPYi4EV
1
3
8
Probably the most useful ep we've done recently. Fascinating! #medtwitter #FOAMed #FOAMcc #meded #pulmcc #ventrounds. Quick tips from @EMNerd_ on APRV: đź§µ
Are you "APRV curious" but lacking the practical know-how? @EMNerd_ tells all: how to start it, the common pitfalls, how to wean and transition, whether it's lung protective, and more. #medtwitter #FOAMcc #FOAMed #meded #pulmcc #ventrounds #some4mv
https://t.co/00uMPYi4EV
1
1
4
The esteemed @EMNerd_ presenting an updated framework for thinking about IV Fluids in critically ill patients at @UMEmergencyMed Crit Care Symposium
0
1
5